Product Details
| Cat.No. | EDC07897 | Product Name | MAP4K4 Knockout HAP1 Cell Line |
|---|---|---|---|
| Species | Human | Cell Line | HAP1 |
| Cellosaurus ID | CVCL_0F62 | Cell Line Synonyms | Highly Aggressively Proliferating Immortalized |
| NCBI Gene ID | Gene | ||
| Gene Synonyms | FLH21957|HEL-S-31|HGK|MEKKK4|NIK | Summary |
The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase has been shown to specifically activate MAPK8/JNK. The activation of MAPK8 by this kinase is found to be inhibited by the dominant-negative mutants of MAP3K7/TAK1, MAP2K4/MKK4, and MAP2K7/MKK7, which suggests that this kinase may function through the MAP3K7-MAP2K4-MAP2K7 kinase cascade, and mediate the TNF-alpha signaling pathway. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
|
| Digestion Time | 2 min | Morphology | Adherent |
| Passage Ratio | 1:8~1:10 | Complete Culture Medium | IMDM+10%FBS |
| Freezing Medium | 90%FBS+10%DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
FAQ
Which is better for studying MAP4K4 function, MAP4K4 Knockout HAP1 Cell Line or MAP4K4 overexpression HAP1 Cell Line?
The choice depends on whether you are studying MAP4K4 (HGK, NIK)'s role as a GCK family MAP4K or its functions in metabolic disease, cardiovascular biology, and cancer cell migration. The Knockout line is the standard tool for asking whether MAP4K4 is required for these processes — MAP4K4 activates JNK and other MAPK pathways and has been implicated in insulin resistance, atherosclerosis, and cardiac hypertrophy. Overexpression is useful for studying MAP4K4 gain-of-function.
For metabolic and cardiovascular research, the EDITGENE MAP4K4 Knockout in HAP1 enables study of HGK biology. Rescue with wild-type or kinase-dead MAP4K4 is the standard specificity control. The knockout is a critical specificity tool for MAP4K4 inhibitors (compounds in development for diabetes and cardiovascular disease) — MAP4K4 has emerged as a target for metabolic disease therapy and as a cardioprotective intervention point.
Is this MAP4K4 Knockout HAP1 Cell Line compatible with overexpression rescue experiments?
Yes. MAP4K4 rescue experiments require attention to GCK-IV architecture:
• Construct design: use a codon-modified MAP4K4 sequence with a small C-terminal tag (FLAG, HA). MAP4K4 has N-terminal kinase domain, central regulatory region, and C-terminal CNH domain — preserve all elements.
• Kinase-dead rescue: K54R or D152A mutations abolish catalytic activity.
• CNH-domain-mutant rescue: CNH domain mutations may affect substrate recruitment or scaffolding.
• Functional readout: rescue should restore MAP4K4-dependent substrate phosphorylation and metabolic/migratory phenotypes.
HAP1-specific considerations:
• Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay.
• Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended.
• Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.